
IZUMI Bio, Inc., is using the power of induced pluripotent stem (iPS) cells to transform drug discovery and regenerative medicine.
Let’s Watch this Company
Previous post: Smart Biotechnology Funding
Next post: Pfizer Eyes New Use For ADULT Stem Cells









Sign Up for the CBC Email Newsletter